Kuros Biosciences AG / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €81.69M +125.1% -€4.02M -72.9% -4.9% +0.36 pp €4.60M -149.9% 5.6% +0.31 pp
    €36.29M +86.6% -€14.84M -5.9% -40.9% +0.40 pp -€9.21M +22.6% -25.4% +0.13 pp
    €19.45M +30.2% -€15.78M +93.5% -81.1% -0.27 pp -€7.51M +36.8% -38.6% -0.019 pp
    €14.94M +242.0% -€8.15M -34.5% -54.6% +2.3 pp -€5.49M -43.7% -36.8% +1.9 pp
    €4.37M +57.7% -€12.46M +2.4% -285.2% +1.5 pp -€9.75M -16.0% -223.3% +2.0 pp
    €2.77M +258.2% -€12.17M -3.8% -439.4% +12 pp -€11.60M -11.9% -419.0% +13 pp
    €773.06K +33.9% -€12.64M -29.1% -1,635.4% +15 pp -€13.16M +33.7% -1,702.9% +0.021 pp
    €577.36K -49.7% -€17.82M -16.5% -3,086.9% -12 pp -€9.84M +3.0% -1,705.1% -8.7 pp
    €1.15M -83.3% -€21.35M -417.1% -1,860.9% -20 pp -€9.56M +251.8% -833.5% -7.9 pp
    €6.87M +535.5% €6.73M -118.3% 98.0% +35 pp -€2.72M -89.4% -39.6% +23 pp
    €1.08M +0.0% -€36.79M +10.4% -3,402.6% -3.2 pp -€25.67M +24.4% -2,373.8% -4.7 pp
    €1.08M -9.1% -€33.33M +234.5% -3,082.6% -22 pp -€20.63M +65.7% -1,907.8% -8.6 pp
    €1.19M -30.0% -€9.96M -50.9% -837.8% +3.6 pp -€12.45M +33.5% -1,046.6% -5.0 pp
    €1.70M -93.0% -€20.30M +1,191.5% -1,195.4% -12 pp -€9.32M +85.2% -548.9% -5.3 pp
    €24.16M +145.4% -€1.57M -94.1% -6.5% +2.7 pp -€5.03M -69.4% -20.8% +1.5 pp
    €9.85M -53.8% -€26.84M -4.5% -272.6% -1.4 pp -€16.45M -44.5% -167.0% -0.28 pp
    €21.32M -45.0% -€28.12M +278.3% -131.9% -1.1 pp -€29.65M +689.9% -139.1% -1.3 pp
    €38.80M +4,856.1% -€7.43M -80.1% -19.2% +48 pp -€3.75M -87.1% -9.7% +37 pp
    €782.79K -83.4% -€37.36M +21.3% -4,772.4% -41 pp -€29.08M +8.0% -3,714.4% -31 pp
    €4.71M +6.0% -€30.79M +19.4% -653.5% -0.74 pp -€26.91M +23.2% -571.1% -0.80 pp
    €4.45M -€25.79M -580.0% -€21.84M -491.3%

    Notifications